Get the Stockscreener App
2.445
0.61%
-0.015
Seastar Medical Holding Corp stock is traded at $2.445, with a volume of 34,913.
It is down -0.61% in the last 24 hours and down -27.90% over the past month.
SeaStar Medical Holding Corp is a medical technology company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs. It is developing and commercializing extracorporeal therapies that target the effector cells that drive systemic inflammation, causing direct tissue damage and secreting a range of pro-inflammatory cytokines that initiate and propagate imbalanced immune responses. The Company is comprised of a single reportable segment, which is its Device Segment.
See More
Previous Close:
$2.46
Open:
$2.45
24h Volume:
34,913
Relative Volume:
0.20
Market Cap:
$9.35M
Revenue:
-
Net Income/Loss:
$-26.23M
P/E Ratio:
-1.992
EPS:
-1.2274
Net Cash Flow:
$-10.29M
1W Performance:
+1.87%
1M Performance:
-27.90%
6M Performance:
-69.81%
1Y Performance:
-87.71%
1-Day Range:
$2.40
$2.57
1-Week Range:
$2.2925
$2.8099
52-Week Range:
$2.20
$30.70
Seastar Medical Holding Corp Stock (ICU) Company Profile
Name
Seastar Medical Holding Corp
Sector
Industry
Phone
844-427-8100
Address
3513 BRIGHTON BLVD, DENVER
Compare ICU with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ICU
Seastar Medical Holding Corp
|
2.46 | 9.35M | 0 | -26.23M | -10.29M | -1.2274 |
|
VRTX
Vertex Pharmaceuticals Inc
|
472.11 | 122.84B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
810.92 | 85.37B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
396.63 | 55.82B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
796.02 | 50.67B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
169.69 | 37.54B | 447.02M | -1.18B | -906.14M | -6.1812 |
Seastar Medical Holding Corp Stock (ICU) Latest News
SeaStar Medical announces 2026 milestones - TipRanks
SeaStar Medical Announces 2026 Milestones - The Manila Times
SeaStar Medical to Present at Biotech Showcase 2026 Investor Conference and Engage with Investors at J.P. Morgan Healthcare Conference - Quiver Quantitative
SeaStar Medical to Present at Upcoming Biotech Showcase 2026 Investor Conference - Yahoo Finance
SeaStar Medical Holding Corp trading halted, news pending - MSN
How SeaStar Medical Holding Corporation stock compares to industry benchmarksMean Reversion Trades & Free Real-Time Trading Signals - bollywoodhelpline.com
SeaStar Medical Stock Scheduled to Reverse Split on Monday, January 5th (NASDAQ:ICU) - Defense World
12 Health Care Stocks Moving In Friday's Intraday Session - Benzinga
SeaStar Medical, Jet.AI And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session - Benzinga
SeaStar Medical announces reverse split - Medical Buyer
SeaStar Medical stock tumbles after announcing 1-for-10 reverse split - Investing.com India
SeaStar Medical announces 1-for-10 reverse stock split effective Jan 5 - Investing.com Nigeria
SeaStar Medical stock tumbles after announcing 1-for-10 reverse split By Investing.com - Investing.com South Africa
SeaStar Medical Holding Corporation Announces 1-for-10 Reverse Stock Split Effective January 5, 2026 - Quiver Quantitative
Why this medical company is turning 10 shares into 1 to stay on Nasdaq - Stock Titan
Baird Jennifer a, director at Seastar Medical, buys $987 in stock - Investing.com UK
SeaStar Medical Stock Scheduled to Reverse Split on Friday, January 2nd (NASDAQ:ICU) - Defense World
What sentiment indicators say about SeaStar Medical Holding Corporation stockMarket Sentiment Review & High Yield Equity Trading Tips - Улправда
What insider trading reveals about SeaStar Medical Holding Corporation Equity Warrant stockEarnings Recap Summary & Stock Portfolio Risk Control - Улправда
Why analysts upgrade SeaStar Medical Holding Corporation Equity Warrant stock2025 Dividend Review & AI Enhanced Trading Signals - Улправда
What's Going On With Shares Of SeaStar Medical Today? - Benzinga
Is SeaStar Medical Holding Corporation Equity Warrant stock ready for breakoutPortfolio Gains Report & Real-Time Market Trend Scan - Улправда
Treasury Yields: How SeaStar Medical Holding Corporation Equity Warrant stock reacts to bond yieldsWeekly Stock Analysis & Accurate Intraday Trading Signals - ulpravda.ru
Why Oracle Shares Are Trading Higher By Over 5%; Here Are 20 Stocks Moving Premarket - Sahm
How buybacks impact SeaStar Medical Holding Corporation stock valueTrade Entry Report & Weekly High Conviction Trade Ideas - Улправда
Can SeaStar Medical Holding Corporation stock sustain institutional interestWeekly Investment Recap & Reliable Price Breakout Alerts - Улправда
Is SeaStar Medical Holding Corporation stock attractive for income investorsBuy Signal & Fast Exit Strategy with Risk Control - Улправда
SeaStar Medical shareholders approve 1-for-10 reverse stock split and authorized share reduction - Investing.com
SeaStar Medical shareholders approve 1-for-10 reverse stock split and authorized share reduction By Investing.com - Investing.com South Africa
SeaStar Medical (ICU) okays 1-for-10 reverse split and cuts authorized shares - Stock Titan
Will SeaStar Medical Holding Corporation Equity Warrant stock rally after Fed decisionsEarnings Miss & AI Optimized Trading Strategy Guides - Улправда
SeaStar Medical receives Nasdaq public reprimand - MSN
CFO Messinger Buys 14,500 ($5.1K) Of SeaStar Medical Holding Corp [ICU] - TradingView — Track All Markets
MESSINGER MICHAEL Insider Trades - Nasdaq
SeaStar Medical Holding Corp (ICU) CFO discloses 3,000-share ownership - Stock Titan
ICU SEC FilingsSeaStar Medical Holding Corp 10-K, 10-Q, 8-K Forms - Stock Titan
SeaStar Medical Holding (ICUCW) Stock Analysis Report | Financials & Insights - Benzinga
Check out these key findings about SeaStar Medical Holding Corp (ICU) - setenews.com
SeaStar Medical Announces FDA Approval for Reduced Patient Surveillance Requirement in SAVE Registry, Enhancing QUELIMMUNE Market Potential - Quiver Quantitative
SeaStar Medical (Nasdaq: ICU) gets FDA nod as SAVE registry cut to 50 patients - Stock Titan
Is SeaStar Medical Holding Corporation stock a safe haven assetTrade Analysis Report & Long-Term Safe Investment Plans - Newser
SeaStar Medical Announces FDA Approval of Reduction in Mandatory Enrollment for SAVE Surveillance Registry Evaluating QUELIMMUNE™ Safety for Pediatric AKI - Yahoo Finance
Can SeaStar Medical Holding Corporation stock beat analyst upgrades2025 Key Lessons & Real-Time Chart Pattern Alerts - moha.gov.vn
Aug Update: How currency fluctuations impact SeaStar Medical Holding Corporation Equity Warrant stock2025 Technical Patterns & Fast Entry Momentum Trade Alerts - moha.gov.vn
Biotech And Healthcare Names Lead After-Hours Gainers: ICU, CGTX, MESO, VRCA, AHCO - Nasdaq
[424B5] SeaStar Medical Holding Corp Prospectus Supplement (Debt Securities) - Stock Titan
SeaStar Medical to Present at NobleCon21 Emerging Growth Equity Conference on December 3rd - Quiver Quantitative
SeaStar Medical (Nasdaq: ICU) to present at NobleCon21 emerging growth conference - Stock Titan
Why SeaStar Medical Holding Corporation stock is considered a top pickInsider Selling & Daily Chart Pattern Signal Reports - newser.com
Is SeaStar Medical Holding Corporation Equity Warrant stock attractive for retirement portfolios2025 Trading Recap & Low Risk High Win Rate Picks - newser.com
Can SeaStar Medical Holding Corporation stock maintain operating margins - newser.com
Seastar Medical Holding Corp Stock (ICU) Financials Data
Revenue
Net Income
Cash Flow
EPS
Seastar Medical Holding Corp Stock (ICU) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Messinger Michael | Chief Financial Officer |
Dec 09 '25 |
Buy |
0.35 |
14,500 |
5,098 |
17,500 |
| Van Heel Kenneth | Director |
Aug 26 '25 |
Buy |
0.89 |
25,000 |
22,248 |
39,400 |
| Van Heel Kenneth | Director |
Aug 27 '25 |
Buy |
0.86 |
10,000 |
8,565 |
49,400 |
| Chung Kevin | Chief Medical Officer |
Aug 22 '25 |
Buy |
0.80 |
10,000 |
8,000 |
58,184 |
| Neuman John | Director |
Jun 04 '25 |
Option Exercise |
0.00 |
2,667 |
0 |
88,000 |
| Vincent Bernadette N | Director |
Jun 04 '25 |
Option Exercise |
0.00 |
2,667 |
0 |
8,000 |
| Van Heel Kenneth | Director |
Jun 04 '25 |
Option Exercise |
0.00 |
4,000 |
0 |
10,400 |
| Chung Kevin | Chief Medical Officer |
Jul 01 '25 |
Option Exercise |
0.00 |
5,000 |
0 |
48,184 |
| Schlorff Eric | Chief Executive Officer |
Jul 01 '25 |
Option Exercise |
0.00 |
21,667 |
0 |
98,517 |
| Baird Jennifer A | Director |
Jun 04 '25 |
Option Exercise |
0.00 |
2,667 |
0 |
18,000 |
5.77%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):